GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tong Ren Tang Technologies Co Ltd (HKSE:01666) » Definitions » YoY EBITDA Growth

Tong Ren Tang Technologies Co (HKSE:01666) YoY EBITDA Growth : 3.93% (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Tong Ren Tang Technologies Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tong Ren Tang Technologies Co's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 3.93%.

Tong Ren Tang Technologies Co's EBITDA per Share for the six months ended in Jun. 2024 was HK$0.61.


Tong Ren Tang Technologies Co YoY EBITDA Growth Historical Data

The historical data trend for Tong Ren Tang Technologies Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tong Ren Tang Technologies Co YoY EBITDA Growth Chart

Tong Ren Tang Technologies Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.92 19.55 11.04 2.70 -4.58

Tong Ren Tang Technologies Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.85 24.27 10.38 -24.87 3.93

Tong Ren Tang Technologies Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tong Ren Tang Technologies Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(1.271-1.332)/ | 1.332 |
=-4.58 %

Tong Ren Tang Technologies Co's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(0.608-0.585)/ | 0.585 |
=3.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tong Ren Tang Technologies Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Tong Ren Tang Technologies Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Tong Ren Tang Technologies Co Business Description

Traded in Other Exchanges
Address
No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
Executives
Citigroup Inc. 2502 Approved lending agent
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Aberdeen Asset Management Plc And Its Associates 2102 Investment manager

Tong Ren Tang Technologies Co Headlines

No Headlines